Etesevimab - Research Grade Biosimilar, CAS [[2423948-94-9]], Unconjugated, Recombinant

Produktübersicht

• Artikelname: Etesevimab - Research Grade Biosimilar, CAS [[2423948-94-9]], Unconjugated, Recombinant
• Artikelnummer: BYT-ORB1237987
• Hersteller Artikelnummer: orb1237987
• Alternativnummer: BYT-ORB1237987-0.1
• Hersteller: Biorbyt
• Kategorie: Antikörper
• Immunogen: Homo sapiens / SARS-CoV-2 Spike RBD
• Konjugation: Unconjugated
• Alternative Synonym: ANTI-SARS-COV-2 ANTIBODY JS016,CB6 CB-6,ETESEVIMAB,ETESEVIMAB [INN],ETESEVIMAB [USAN],ETESEVIMAB [WHO-DD] IMMUNOGLOBULIN G1 (236-ALANINE,237-ALANINE), ANTI-(SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 SPIKE GLYCOPROTEIN RECEPTOR-BINDING DOMAIN) (HUMAN MONOCLONAL JS016 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL JS016 .KAPPA.-CHAIN, DIMER IMMUNOGLOBULIN G1 (236-ALANINE,237-ALANINE), ANTI-(SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 SPIKE GLYCOPROTEIN) (HUMAN MONOCLONAL LY3832479 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL LY3832479 .KAPPA.-CHAIN, DIMER JS016 JS-016 LY COV016 LY3832479 LY-3832479 LY-COV016 NP005 NP-005, spike glycoprotein

Produktbeschreibung

Etesevimab - Research Grade Biosimilar

Produkteigenschaften

• Klonalität: Recombinant
• Konzentration: batch dependent
• NCBI: 0
• UniProt: P0DTC2
• Puffer: PBS buffer pH 7.5
• Reinheit: >95%
• CAS Nummer: [2423948-94-9]
• Target-Kategorie: S